Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

google.co.in

Google Alert - evommune

Get the latest updates from Google Alert - evommune directly as they happen.

Follow now 114 followers

Latest posts

Last updated 5 days ago

Small molecule therapy(Evommune/Accutar Biotechnology)-靶点_适应症: 炎性疾病-临床

6 days ago

Small molecule therapy(Evommune/Accutar Biotechnology)是由Evommune Inc和冰洲石生物科技研发的一种小分子药物,目前该药物最高研发阶段为临床前, ...

Brian S. Kim on X: "Thank you to Evommune for sponsoring our Allen Discovery Center-Cell ...

6 days ago

Thank you to Evommune for sponsoring our Allen Discovery Center-Cell Symposia. Early...

Evommune | B Capital Job Board

11 days ago

Evommune is different. We strive to develop accessible innovations that are meant...

Evommune Scientist Medicinal Chemistry Job in Palo Alto, CA - ZipRecruiter

17 days ago

Evommune, Inc. is a private clinical-stage biotechnology company dedicated to revolutionizing the...

Venture Round - Evommune - 2025-01-07 - Crunchbase Funding Round Profile

20 days ago

Evommune raised $81799952 on 2025-01-07 in Venture Round.

Anteris Appoints David Roberts and Gregory Moss to its Board of Directors

23 days ago

Prior to Evommune, Mr. Moss served as Executive Vice President, General Counsel...

Lorena Riol-Blanco | 49 comments - LinkedIn

30 days ago

... Evommune for giving me the opportunity to step into an executive...

SHC Portfolio | 上海阿尔法分子获批中国药监局和美国药监局临床许可医药新闻 - ByDrug

about 1 month ago

2025年5月28日,美国Evommune公司公布该靶点临床2a积极结果,在安全性和药效上均达到慢性荨麻疹治疗的主要治疗终点。 与EVO-756相比,AM-001具有潜在更大的安全窗口 ...

上海阿尔法分子获批中国药监局和美国药监局临床许可 - ByDrug - 医药魔方

about 1 month ago

2025年5月28日,美国Evommune 公司公布该靶点临床2a积极结果,在安全性和药效上均达到慢性荨麻疹治疗的主要治疗终点。临床上一天口服一次300mg或者一天口服两次 ...

拜耳突破性小分子获FDA优先审评资格;潜在“first-in-class”小分子积极2期试验结果公布 - 网易

about 1 month ago

Evommune今日公布其潜在“first-in-class”在研小分子EVO756在成人慢性诱导性荨麻疹(CIndU)患者中的2期试验积极顶线数据。该数据支持EVO756在CIndU和特应性 ...

Taysha's pivotal trial plans; Keros to stop work on PAH drug, lay off 45% of staff

about 1 month ago

Plus, news about Immunic, Neurocrine Biosciences, Alcon, AusperBio and Evommune: Taysha Gene...

Evommune is proud to announce that Lorena Riol-Blanco, our Vice President - LinkedIn

about 1 month ago

Evommune is proud to announce that Lorena Riol-Blanco, our Vice President, Biology...